STEELE TESCHER: Open Payments
NPI 1851642847 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 67 payments from 24 companies in 2025. Trend: 2023 $894 · 2024 $1,387 · 2025 $1,154
Food & beverage: $1,154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $163 |
| Novartis Pharmaceuticals Corporation | 8 | $148 |
| Inspire Medical Systems, Inc. | 4 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| Dexcom, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $65 |
| Amgen Inc. | 4 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Lilly USA, LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
Products named: LEQVIO, VRAYLAR, INSPIRE, Dexcom G6 Transmitter, Veozah, CAMZYOS, ENTYVIO, CAPLYTA.
Industry payments across ND — which companies pay providers there.
